6,505
Participants
Start Date
September 30, 2006
Primary Completion Date
April 30, 2010
Study Completion Date
April 30, 2010
Ivabradine
2.5mg, 5mg or 7.5mg tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 42 months.
Placebo
Matching placebo tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 42 months.
Hôpital Pitié-Salpétrière, Paris
Göteborg University, Gothenburg
Institut de Recherches Internationales Servier
OTHER